Common Contracts
3 similar Severance Agreement contracts by Poniard Pharmaceuticals, Inc.
PONIARD PHARMACEUTICALS, INC. KEY EXECUTIVE SEVERANCE AGREEMENT (VP)Severance Agreement • August 14th, 2006 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
This Key Executive Severance Agreement (VP) (this “Agreement”), dated as of July 24, 2006, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 10, the “Company”), and Alan B. Glassberg, M.D. (the “Executive”).
PONIARD PHARMACEUTICALS, INC. KEY EXECUTIVE SEVERANCE AGREEMENT (VP)Severance Agreement • June 23rd, 2006 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
This Key Executive Severance Agreement (VP) (this “Agreement”), dated as of July 1, 2006, is entered into by and between PONIARD PHARMACEUTICALS, INC. (formerly NeoRx Corporation), a Washington corporation (as supplemented by Section 10, the “Company”), and Cheni Kwok (the “Executive”).
PONIARD PHARMACEUTICALS, INC. KEY EXECUTIVE SEVERANCE AGREEMENT (VP)Severance Agreement • June 23rd, 2006 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
This Key Executive Severance Agreement (VP) (this “Agreement”), dated as of June 23, 2006, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 10, the “Company”), and Caroline M. Loewy (the “Executive”).
